Kkr

"It really does feel like our type of capital is welcome here and private capital naturally wants to go where it’s welcomed," the top private equity executive said alluding to the investment friendly regime under the Indian government.

KKR-backed Vertis hires three banks for India IPO, to seek approval by December: Report

A planned IPO for Vertis comes as Indian markets are trading near record highs

Rising domestic investor demand spurs record secondary trades in InvITs

In the last two months, seven InvITs have seen secondary transactions worth almost Rs 6,000 crore, data from stock exchanges shows

Piramal, KKR seek exit from Shriram General Life Insurance: Sources

Both investors are said to have initiated the exit process and are mulling various options including a listing for the company or a secondary sale.

Mizuho–Avendus deal enters final stage of conclusion

Sources say some of the valuation and deal terms related aspects which was holding up the acquisition since June have now been ironed out. The deal closure is likely soon.

Macquarie’s $1.3-billion TOT roads sale draws interest from KKR, Cube, CDPQ, IRB and EAAA

The portfolio consists of road projects spanning 648 km across Andhra Pradesh and Gujarat. Macquarie is open to selling the portfolio as a whole or in three smaller packages, depending on buyer appetite

With KKR on board, Kerala’s Meitra Hospital to expand to other southern states, says founder Kottikollon

About 5% of Meitra’s revenue comes from overseas patients, largely from Oman. The share is expected to triple once additional capacity comes onstream, Faizal Kottikollon tells Moneycontrol

Rs 2 lakh crore worth of road assets up for monetisation in next 5 years, says Vertis Infra Trust CEO

InvITs have democratised infrastructure investing by offering Indian investors stable, inflation-hedged yields with strong governance, the KKR-backed roads InvIT CEO Gaurav Chandna tells Moneycontrol

KEF Holdings’ Meitra Hospital joins KKR’s healthcare platform in India

Founded by entrepreneur Faizal Kottikollon in 2012, Meitra Hospital is a JCI accredited, advanced quaternary care hospital of international standards located in Kozhikode

3 IPOs in pipeline, KKR’s Asia infra fund set for up to $700 million in exits

KKR has invested in roads and renewables through its Asia funds, deploying a significant portion of its collective $7 billion capital in India

InvIT IPOs gain momentum with deals worth over Rs 20,000 crore in the pipeline

India’s InvIT market has seen just four IPOs after the first such trust, IRB InvIT Fund, went public in 2017

‘My life, my game, my career’: After IPL failure, Venkatesh Iyer blocks out the naysayers

Despite being benched for a few IPL 2025 matches, Madhya Pradesh all-rounder Venkatesh Iyer maintains that the KKR management never lost faith in him.

Brookfield’s CleanMax, KKR-backed Hero Future Energies may file draft IPO papers by next week

Hero Future Energies is looking to raise around Rs 4,000 crore and CleanMax around Rs 5,000 crore

KKR may sell up to $300-million stake in Vertis Infrastructure Trust

KKR has a 71.66 percent stake followed by Ontario Teachers’ Pension Plan, which holds 24.99 percent in the roads infrastructure investment trust

KKR, Cube road InvITs plan IPO, may raise up to Rs 5,000 crore each

The move is aimed at tapping a wider pool of investors to meet growth capital requirements amid a rising demand for high-yield generating assets

India a 'standout investment destination' amid global volatility: KKR

KKR 2025 Mid-Year Global Macro Outlook report expects India's growth to remain resilient, supported by a strong domestic consumer market and structural reforms

KKR releases mid-year global macro outlook, urges investors to ‘make their own luck’ amid volatility

Rather than leaning into broad beta exposure, the firm recommends emphasising “control” in portfolios, whether through private equity investments with operational levers, or real assets offering inflation-linked cash flows

Macquarie prepares to sell its TOT road bundle for $1.5 billion

If the entire portfolio of nine roads is sold, it will be the biggest such deal in India, exceeding KKR’s acquisition of 13 roads from PNC Infratech for Rs 9,000 crore

Avendus sale faces delay as KKR, Gaja Capital squabble over exit premium

The deal, valued at approximately $700 million, will mark Mizuho's biggest investment in India, reflecting a major commitment to the Indian market

Torrent Pharma revives talks to acquire KKR’s stake in JB Pharma; deal expected soon

KKR’s stake is worth approximately Rs 13,400 crore considering the J B Pharma stock’s closing price of Rs 1,802.9 per share on June 27.

Cliffhanger sale of KKR - backed Avendus Capital: Carlyle back in fray as talks with Mizuho slow down

On February 20 , 2024, Moneycontrol was the first to report that KKR had revived the process to exit the leading home-grown firm.  Slowing down of discussions between Mizuho Financial Group and KKR backed Avendus Capital over "softer deal terms" do not necessarily mean that the Japanese group is out of the race, sources said.

KKR-backed InCred’s private credit arm to raise $174 million

The fund-raising underscores the growing need for capital in one of the world’s fastest-growing major economies

JB Chemicals Block Deal: Stock falls 7% as 90 lakh shares exchanged, KKR likely seller

Around 5.8 percent equity of JB Chemicals changed hands in a block deal, with KKR, the promoter of JB Chemicals and Pharmaceuticals, being the likely seller.

IPL 2025: Venkatesh Iyer unfazed by price tag pressure, focused on delivering for KKR

KKR's newly-appointed skipper Ajinkya Rahane seemed visibly irritated by the repeated discussions around Iyer's price tag and said he "deserved that price".

IPL: What Shah Rukh Khan thought on Gautam Gambhir's return to KKR in 2024

After a ten-year break, KKR won their third IPL title thanks in large part to Gambhir's return.